Long‐Term Clinical Outcomes of Transurethral Resection of Hunner Lesions Combined With Bladder Hydrodistension for Patients With Interstitial Cystitis at a Tertiary Referral Center in Japan
International Journal of Urology · 2025
DOI: 10.1111/iju.70227 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, 2025. Verfasst von Yoshiyuki Akiyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shinshu University School of Medicine, Nagano, Japan. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Cystoscopy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objectives
To report the long‐term clinical outcomes of transurethral resection of Hunner lesions with bladder hydrodistension in patients with Hunner lesion interstitial cystitis (HIC) at a tertiary referral center in Japan.
Methods
A retrospective chart review was conducted to evaluate the treatment outcomes of 104 patients with HIC who underwent initial endoscopic surgery, including transurethral resection of Hunner lesions (ablation was kept to a minimum) and concomitant bladder hydrodistension between 2017 and 2023. Clinical outcomes were evaluated and compared between each follow‐up visit and baseline over 12 months using a 7‐graded global response assessment (GRA), O'Leary and Sant's symptom and problem indices (OSSI/OSPI), an 11‐point pain intensity numerical rating scale, quality of life (QOL) score, and frequency volume chart variables. Patients with GRA scores ≥ +2 (moderately/marked improved) and scores ≤ −1 (slightly/moderately/marked worse) were considered treatment responders and failures, respectively. Postoperative complications were also documented.
Results
The mean duration to treatment failure was 30.9 ± 21.0 months. The overall response rates at 1, 3, 6, 9, and 12 months were 78.8%, 80.8%, 76.0%, 69.2%, and 57.7%, respectively. Compared with the baseline, the OSSI/OSPI, pain intensity, QOL score, urinary frequency, and functional bladder capacity improved significantly after 1 month and were maintained over 12 months. One patient required a second surgery for postoperative bleeding and another developed distal urethral stenosis 6 months post‐surgery. No other patients developed any postoperative complications.
Conclusions
Transurethral resection of Hunner lesions combined with bladder hydrodistension offers long‐term symptom relief without serious adverse events for treatment‐naïve patients with HIC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Shinshu University School of Medicine, Nagano, Japan.
- Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Interstitial Cystitis Medicine, Kyorin University School of Medicine, Tokyo, Japan.
ORCID-Profile: Yoshiyuki Akiyama
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Akiyama, Y., Hashimoto, K., Niimi, A., Homma, Y., & Kume, H. (2025). Long‐Term Clinical Outcomes of Transurethral Resection of Hunner Lesions Combined With Bladder Hydrodistension for Patients With Interstitial Cystitis at a Tertiary Referral Center in Japan. International Journal of Urology. https://doi.org/10.1111/iju.70227
Vancouver
Akiyama Y, Hashimoto K, Niimi A, Homma Y, Kume H. Long‐Term Clinical Outcomes of Transurethral Resection of Hunner Lesions Combined With Bladder Hydrodistension for Patients With Interstitial Cystitis at a Tertiary Referral Center in Japan. International Journal of Urology. 2025. doi:10.1111/iju.70227
BibTeX
@article{Akiyama2025,
author = {Akiyama, Yoshiyuki and Hashimoto, Kenichi and Niimi, Aya and Homma, Yukio and Kume, Haruki},
title = {Long‐Term Clinical Outcomes of Transurethral Resection of Hunner Lesions Combined With Bladder Hydrodistension for Patients With Interstitial Cystitis at a Tertiary Referral Center in Japan},
journal = {International Journal of Urology},
year = {2025},
doi = {10.1111/iju.70227}
}
EUVIMED